Molecular Characterization of Plasmodium Species to Strengthen Malaria Surveillance in Migrant Populations in Honduras
As Honduras approaches malaria elimination, imported infections pose a growing challenge to disease surveillance and control. In this study, we analyzed 14 molecular markers-six from <i>Plasmodium falciparum</i> and eight from <i>P. vivax</i>-in samples from local and migrant subjects to assess their utility in differentiating local versus imported infections. All <i>P. falciparum</i> isolates carried the wild-type <i>pfcrt</i> haplotype associated with chloroquine susceptibility. However, polymorphisms in <i>pfmdr1</i>, <i>pfama1</i>, <i>pfglurp</i>, and <i>pfs47</i> revealed distinct genotypes in migrant versus local samples, suggesting external origins. For <i>P. vivax</i>, three novel <i>pvcsp</i> VK210 haplotypes and the first detection of a VK247 variant in Honduras were identified in migrants. Additional novel haplotypes were found in <i>pvmsp1</i>, <i>pvmsp3α</i>, <i>pvmsp3β</i>, <i>pvs47</i>, and <i>pvs48</i>/45. Several of these markers-particularly <i>pfmdr1</i>, <i>pfs47</i>, <i>pvs47</i>, and <i>pvs48</i>/45-proved informative for inferring geographic origin. This study demonstrates the value of molecular surveillance in low-transmission settings, supporting public health efforts by identifying potentially imported cases.
Authors
- Hugo O. Valdivia (ORCID: https://orcid.org/0000-0003-2159-5667)
- Gustavo Fontecha (ORCID: https://orcid.org/0000-0001-9756-4520)
- Alejandra Pinto (ORCID: https://orcid.org/0000-0003-3890-0218)
- Alcides Godoy
- Lesly Chaver
- Gloria Ardón
- Kevin Euceda
Institutions
- National Autonomous University of Honduras (HN)
- United States Naval Medical Research Unit SOUTH (PE)
- National Autonomous University of Honduras (HN)
Publication Details
- Journal
- Tropical Medicine and Infectious Disease
- Published
- 2025-10-15
- DOI
- https://doi.org/10.3390/tropicalmed10100292
- Primary Topic
- Malaria Research and Control
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases